Evidence map›Paper›PMID 39802231›Full record

ArticleIJTLD open2025

The impact of the war in Ukraine on the prevalence of MDR/RR-TB in Poland.

A Nowinski, E Augustynowicz-Kopeć, J Garnczarek, A Halicka, M Koszela, W Litwiniuk, D Maj, I Mazur, J Niestrój-Ostrowska, R Podlasin and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in IJTLD open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

A NowinskiDepartment of Tuberculosis Epidemiology and Surveillance, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland.
E Augustynowicz-KopećDepartment of Microbiology, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland.
J GarnczarekSecond Lung Disease Department in Tuszyn, Center for the Treatment of Lung Diseases and Rehabilitation, Lodz, Poland.
A HalickaWielkopolskie Center of Pulmonology and Thoracic Surgery, Poznan, Poland.
M KoszelaLower Silesian Oncology, Pulmonology and Hematology Center, Wrocław, Poland.
W LitwiniukDepartment of Tuberculosis and Lung Diseases Treatment, Kuyavian-Pomeranian Pulmonology Centre, Bydgoszcz, Poland.
D MajIndependent Public Tuberculosis and Lung Diseases Sanatorium, Tuberculosis and Lung Diseases Department, Poniatowa, Poland.
I MazurMałopolski Hospital for Lung Diseases and Rehabilitation, Jaroszowiec, Poland.
J Niestrój-OstrowskaHospital for Lung Diseases in Pilchowice, Pilchowice, Poland.
R PodlasinFourth Department, Hospital for Infectious Diseases, Warsaw, Poland.
A RegulskaHospital for Lung Diseases and Long-Term Care, Górno, Poland.
M WielopolskaPediatric Department, Mazovian Center for Lung Diseases and Tuberculosis, Otwock, Poland.
J WyrwińskiIndependent Public Provincial Hospital, Department I of Tuberculosis and Lung Diseases, Szczecin Zdunowo, Poland.
S WesołowskiDepartment of Tuberculosis Epidemiology and Surveillance, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland.
M Korzeniewska-KosełaDepartment of Tuberculosis Epidemiology and Surveillance, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe 2022 invasion of Ukraine by the Russian Federation triggered a refugee crisis, affecting the multidrug-/rifampicin-resistant TB (MDR/RR-TB) prevalence in neighbouring countries. This study examines the epidemiological trends and characteristics of MDR/RR-TB patients in Poland, focusing on the relative contribution of Ukrainian refugees.

methodsData from the Polish National Tuberculosis Registry and EPIC Project database, covering MDR/RR-TB cases reported between 2010 and Q1 2024, were analysed.

resultsThe study included 794 MDR/RR-TB cases, showing a demographic shift post-2022. During the 10-year period up to 2021, a median of 48 MDR/RR-TB cases were reported annually in Poland. After 2022, these numbers doubled: 104 cases were reported in 2022 and 101 cases in 2023. Simultaneously, the number of Ukrainian MDR/RR-TB patients increased from 77 (13%) during 2010-2021 to 127 (58%) from 2022 to Q1 2024.

conclusionPoland is observing an increased number of cases of MDR/RR-TB associated with the large number of displaced Ukrainian citizens who are now residing in Poland. There is a need to monitor the epidemiology of MDR/RR-TB and seek optimal screening and management strategies for TB among refugees from countries with high MDR/RR-TB incidence in Poland and Europe.

Indexed as

MDR/RR-TBMDR TBPolandrefugeesUkrainewar

Identifiers

PMID39802231
PMCPMC11724529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.